New
Crisabo Ointment 2% – Non-Steroid Eczema Relief
Crisabo Ointment 2% – Non-Steroid Eczema Relief
Crisabo Ointment 2% – Non-Steroid Eczema Relief
Description
Advanced Non-Steroidal Therapy for Mild-to-Moderate Atopic Dermatitis
Crisabo Ointment 2% (crisaborole) is a cutting-edge, non-steroidal topical treatment for mild to moderate atopic dermatitis (eczema) in children aged 3 months and older and adults. It operates as a selective phosphodiesterase-4 (PDE4) inhibitor that helps reduce inflammation, itching, redness and skin barrier disruption.
Clinical trials demonstrated that twice-daily application significantly improved skin clearance (ISGA 0/1) in patients compared with vehicle and that the safety profile is favourable with minimal systemic absorption.
Crisabo offers a steroid-sparing alternative, making it a valuable option for long-term management of eczema especially when patients seek to avoid topical corticosteroids or calcineurin inhibitors.


